Quantcast
Last updated on April 21, 2014 at 7:52 EDT

Latest hyperglycemia Stories

2009-08-26 07:45:12

Mild glucose intolerance in pregnancy may be an early identifier of women who are at increased risk of heart disease in the future, according to a new Canadian study. As cardiovascular disease is the leading cause of death in Canadian women, it is important to identify early predictors of future vascular risk. While women with gestational diabetes have a higher risk of cardiovascular disease than those without, researchers did not know whether mild glucose intolerance in pregnancy is...

2009-07-30 06:30:30

Older diabetic patients who take antipsychotic medications appear to have an increased risk of hospitalization for hyperglycemia (elevated blood glucose level), especially soon after beginning treatment, according to a new report. The antipsychotic drugs prescribed for older adults with dementia may be associated with adverse effects, including Parkinson's disease symptoms, stroke and diabetes. "The risk of diabetes may be partly related to chronic effects of the weight gain associated with...

2009-06-24 12:25:00

Preliminary Data Demonstrates Reduction of HbA1c Levels With Doses an Order of Magnitude Lower than the Dose Used in the Current Phase 3 Trial. BETHESDA, Md., June 24 /PRNewswire-FirstCall/ -- Spherix Incorporated (Nasdaq CM: SPEX), an innovator in biotechnology for diabetes therapy, and a provider of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies, today announced positive preliminary results from a Phase 2 clinical trial of its...

2009-06-23 10:33:00

Kid Delegates Meet Elected Officials, Testify at Senate Hearing, and Urge Legislators To Request Fund Research WASHINGTON, June 23 /PRNewswire-USNewswire/ -- More than 150 children and teenagers throughout the U.S. with type 1 diabetes are in Washington, D.C. this week to advocate for funding for type 1 diabetes research. They'll be joined by JDRF International Chairman Mary Tyler Moore, Nick Jonas of the Grammy nominated multi platinum group The Jonas Brothers, boxing legend Sugar Ray...

2009-06-09 07:00:00

- SYNCHRONY Study Published in The Lancet Supports Cardio-Protective Potential of Aleglitazar - NUTLEY, N.J., June 9 /PRNewswire/ -- Roche today announced it will start Phase III clinical investigations for aleglitazar, its innovative PPAR co-agonist R1439 which is uniquely designed to reduce cardiovascular morbidity and mortality in high risk patients with type 2 diabetes. This decision is supported by data from the Phase II SYNCHRONY study published today in The Lancet(1) and announced at...

2009-06-06 10:00:00

- A1C and FBG Results for Patients 65 and Under Treated with Lantus and NPH were Similar - NEW ORLEANS, June 6 /PRNewswire-FirstCall/ -- Sanofi-aventis U.S. presented results of a new study, "Safety and Efficacy of Insulin Glargine Compared With NPH Insulin in Older Adults With Type 2 Diabetes: Results from a Pooled Analysis," that examined the safety and efficacy of Lantus(R) (insulin glargine [rDNA origin] injection) compared to insulin NPH in older adults with type 2 diabetes. The study,...

2009-06-06 10:00:00

RIDGEFIELD, Conn., June 6 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. today announced its pipeline of oral antidiabetic compounds, establishing itself in the type 2 diabetes therapeutic area. The Company is investigating compounds in Phase II and Phase III clinical development worldwide. New Phase II data results for linagliptin (BI 1356), a dipeptidyl peptidase 4 (DPP-4) inhibitor and the Company's lead diabetes compound, were presented today at the 69th Annual American...

2009-06-06 10:00:00

Two-year study presented at the American Diabetes Association's 69th Scientific Sessions shows investigational product comparable to standard insulin therapy in pulmonary function tests NEW ORLEANS, June 6 /PRNewswire-FirstCall/ -- AFRESA(R) (insulin human [rDNA origin]) Inhalation Powder is a well-tolerated, ultra rapid acting insulin with changes in pulmonary function tests comparable to usual antidiabetic treatment, according to data presented today at the American Diabetes Association's...

2009-06-02 08:08:00

Agreement to Distribute MEC HbA1c Test To Provide Physicians in U.S. and Europe With Fast, Accurate Near-Patient Test for Diabetes Monitoring MADISON, N.J., June 2 /PRNewswire-FirstCall/ -- HemoCue AB, an international company in the field of point-of-care testing and a subsidiary of Quest Diagnostics Incorporated (NYSE: DGX), today announced that it has signed an agreement with MEC Dynamics Corp (MEC) for the exclusive distribution of the Avie(TM) A1c point-of-care test in the United States...

2009-05-14 10:30:00

HOUSTON, May 14 /PRNewswire-USNewswire/ -- Diabetes experts today issued new recommendations for the treatment of prediabetes, a condition affecting 57 million Americans, at the American Association of Clinical Endocrinologists (AACE) 18th Annual Meeting & Clinical Congress. These clinical recommendations include specific instructions for lifestyle intervention and medication. (Logo: http://www.newscom.com/cgi-bin/prnh/20090324/DC88061LOGO-b) They come as a result of the first-ever...